BR8108820A - Processo e sonda de diagnostico - Google Patents

Processo e sonda de diagnostico

Info

Publication number
BR8108820A
BR8108820A BR8108820A BR8108820A BR8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A BR 8108820 A BR8108820 A BR 8108820A
Authority
BR
Brazil
Prior art keywords
probe
diagnostic process
diagnostic
Prior art date
Application number
BR8108820A
Other languages
English (en)
Portuguese (pt)
Inventor
Henry Anthony Erlich
Michael Alan Lovett
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of BR8108820A publication Critical patent/BR8108820A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
BR8108820A 1980-09-24 1981-09-22 Processo e sonda de diagnostico BR8108820A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19036180A 1980-09-24 1980-09-24
US29796281A 1981-09-02 1981-09-02
PCT/US1981/001272 WO1982001011A1 (en) 1980-09-24 1981-09-22 Diagnostic method and probe

Publications (1)

Publication Number Publication Date
BR8108820A true BR8108820A (pt) 1982-08-24

Family

ID=26886027

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8108820A BR8108820A (pt) 1980-09-24 1981-09-22 Processo e sonda de diagnostico

Country Status (10)

Country Link
EP (1) EP0050424B1 (ja)
JP (1) JPS57501692A (ja)
BR (1) BR8108820A (ja)
CA (1) CA1167376A (ja)
DE (1) DE3172347D1 (ja)
DK (1) DK232882A (ja)
ES (1) ES505713A0 (ja)
IL (1) IL63907A0 (ja)
NO (1) NO821569L (ja)
WO (1) WO1982001011A1 (ja)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269567D1 (en) * 1981-04-29 1986-04-10 Ciba Geigy Ag New devices and kits for immunological analysis
FI69639C (fi) * 1982-07-02 1986-03-10 Orion Yhtymae Oy Preparat foer anvaendning vid klamydia-diagnostik
US4863729A (en) * 1984-06-20 1989-09-05 Linus Pauling Institute Of Science And Medicine Method for preparing a macromolecular monoclonal antibody composition
US4647544A (en) * 1984-06-25 1987-03-03 Nicoli David F Immunoassay using optical interference detection
DE3722273A1 (de) * 1986-07-08 1988-01-21 Bio Rad Laboratories Festphasen-bindungsreagentien, ihre herstellung und sie enthaltende assay-kits
NZ221895A (en) * 1986-09-26 1990-09-26 Univ California Composition and method for the diagnosis of pseudomonas aeruginosa infections
US6277592B1 (en) 1996-07-31 2001-08-21 Purina Mills, Inc. Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6297027B1 (en) 1996-07-31 2001-10-02 Purina Mills, Inc. Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6103468A (en) * 1997-10-07 2000-08-15 Labatt Brewing Company Limited Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer
NZ516278A (en) 1999-06-22 2004-03-26 Invitrogen Corp Improved primers and methods for the detection and discrimination of nucleic acids
US6830902B1 (en) 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
US6692918B2 (en) 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
EP1218542B1 (en) 1999-09-13 2004-03-24 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
JP5111706B2 (ja) 1999-12-16 2013-01-09 モンサント テクノロジー エルエルシー 植物における異種ポリペプチドの発現のためのdna構築物
JP2004513617A (ja) 2000-06-26 2004-05-13 ニューゲン テクノロジーズ, インコーポレイテッド 転写に基づく核酸増幅のための方法および組成物
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
EP1366191A2 (en) 2000-12-11 2003-12-03 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification
CA2430329A1 (en) 2000-12-13 2002-06-20 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
US6794141B2 (en) 2000-12-22 2004-09-21 Arcturus Bioscience, Inc. Nucleic acid amplification
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
BR0205268A (pt) 2001-03-09 2004-11-30 Nugen Technologies Inc Processos e composições para a mplificação de sequências de rna
EP1950305A1 (en) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr a genes and uses thereof
EP1411761B1 (en) 2001-05-09 2010-01-20 Monsanto Technology LLC Metabolite transporters
US7291477B2 (en) * 2001-07-03 2007-11-06 Xenotope Diagnostics, Inc. Method and device for trichomonas detection
US7414111B2 (en) 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
AU2002341752B2 (en) 2001-09-19 2008-04-03 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
US20030165859A1 (en) 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
US7211656B2 (en) 2002-01-30 2007-05-01 Abbott Laboratories Desaturase genes, enzymes encoded thereby, and uses thereof
ES2346863T3 (es) 2002-05-15 2010-10-21 Monsanto Technology Llc Procedimiento para aumentar el peso de las semillas de plantas.
AU2003240795A1 (en) 2002-05-24 2003-12-12 Invitrogen Corporation Nested pcr employing degradable primers
WO2004013305A2 (en) 2002-08-05 2004-02-12 Quanta Biosciences, Inc. Improved compositions for in vitro amplification of nucleic acids
EP1546183A4 (en) 2002-09-23 2008-06-18 Du Pont ISOLATION AND USE OF RYANODINE RECEPTORS
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
WO2004092418A2 (en) 2003-04-14 2004-10-28 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
EP1699926B1 (en) 2003-12-10 2014-06-18 Monsanto Technology, LLC Stress tolerant plants and methods thereof
JP4955540B2 (ja) 2004-06-04 2012-06-20 フラクスオーム サイエンセズ エイ/エス 多価不飽和脂肪酸生産のための代謝改変細胞
US7456270B2 (en) 2004-09-01 2008-11-25 Abbott Laboratories Δ6-desaturase genes and uses thereof
CA2581086C (en) 2004-09-14 2023-11-07 The Regents Of The University Of Colorado, A Body Corporate Method for treatment with bucindolol based on genetic targeting
US7790363B2 (en) 2005-02-07 2010-09-07 Abbott Laboratories Inc. Diagnostic test for vitamin B12
US8624027B2 (en) 2005-05-12 2014-01-07 Abbvie Inc. Combination therapy for treating cancer and diagnostic assays for use therein
US8017103B2 (en) 2005-07-01 2011-09-13 Board Of Regents, The University Of Texas System Methods and compositions to diagnose trichomonas infection
CA2619841C (en) 2005-08-16 2012-07-03 Merlogen, Llc Methods for identifying merle mutations in the silv gene
US7939258B2 (en) 2005-09-07 2011-05-10 Nugen Technologies, Inc. Nucleic acid amplification procedure using RNA and DNA composite primers
US7439028B2 (en) 2005-09-30 2008-10-21 Board Of Regents, The University Of Texas System Methods and compositions to correlate Trichomonas infection with prostate cancer
CN101506236B (zh) 2005-11-30 2012-12-12 雅培制药有限公司 抗淀粉样β蛋白的单克隆抗体及其用途
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
US7803567B2 (en) 2005-12-09 2010-09-28 Board Of Regents, The University Of Texas System Methods and compositions for detecting trichomonas in a sample contacted with fixative
US7285388B1 (en) 2006-04-07 2007-10-23 Merlogen, Llc Methods for identification of alport syndrome
US8933209B2 (en) 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
CA2740812C (en) 2006-05-25 2016-01-12 Monsanto Technology Llc A method to identify disease resistant quantitative trait loci in soybean and compositions thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
EP2735619A3 (en) 2007-08-29 2014-08-13 Monsanto Technology LLC Methods and compositions for breeding for preferred traits associated with Goss' Wilt resistance in plants
US8034568B2 (en) 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US8030471B2 (en) 2008-03-06 2011-10-04 Abbott Laboratories Plasmodium malariae and Plasmodium ovale genes and uses thereof
US8268981B2 (en) 2008-03-06 2012-09-18 Abbott Laboratories Plasmodium malariae and plasmodium ovale genes and uses thereof
WO2009117698A2 (en) 2008-03-21 2009-09-24 Nugen Technologies, Inc. Methods of rna amplification in the presence of dna
CN102098909B (zh) 2008-04-24 2014-12-31 孟山都技术有限公司 鉴定大豆中亚洲大豆锈病抗性数量性状基因座的方法和其组合物
ES2466365T3 (es) 2008-10-06 2014-06-10 Abbott Laboratories Genes de Delta-8 desaturasa, enzimas codificadas por los mismos y usos de los mismos
US8288124B2 (en) 2008-11-20 2012-10-16 Abbott Laboratories Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay
JP5651125B2 (ja) 2008-12-10 2015-01-07 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Mek阻害剤に対する耐性を付与するmek突然変異
CA2749945A1 (en) 2009-01-31 2010-08-05 Abbott Laboratories Markers to predict and monitor response to aurora kinase b inhibitor therapy
WO2010093742A1 (en) 2009-02-11 2010-08-19 Abbott Laboratories Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancers
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
CA2761946A1 (en) 2009-05-14 2010-11-18 The Regents Of The University Of California, A California Corporation Carcinoma diagnosis and treatment, based on odc1 genotype
WO2011002936A2 (en) 2009-06-30 2011-01-06 Abbott Laboratories Markers of xmrv infection and uses thereof
US8188335B2 (en) 2009-07-17 2012-05-29 Abbott Laboratories Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
DK2515899T3 (en) 2009-12-23 2016-08-15 Arca Biopharma Inc METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
MX360932B (es) 2010-02-25 2018-11-21 Dana Farber Cancer Inst Inc Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf.
CN103038364A (zh) 2010-03-09 2013-04-10 达纳-法伯癌症研究所公司 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
US20130217743A1 (en) 2010-05-14 2013-08-22 Cancer Prevention Pharmaceuticals, Inc. Cancer prevention and treatment methods based on dietary polyamine content
US20130143911A1 (en) 2010-06-09 2013-06-06 Dana-Farber Cancer Institute, Inc. MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors
JP6147665B2 (ja) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド アミロイドベータ結合タンパク質
US20120058462A1 (en) 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
WO2012024513A2 (en) 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
US10172305B2 (en) 2011-04-29 2019-01-08 Monsanto Technology Llc Diagnostic molecular markers for seed lot purity traits in soybeans
HUE044521T2 (hu) 2011-08-31 2019-10-28 Seminis Vegetable Seeds Inc Görögdinnye szilárdságával kapcsolatos eljárások és kompozíciók
US10314253B2 (en) 2012-12-04 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and compositions for watermelon sex expression
US10294489B2 (en) 2013-03-15 2019-05-21 Board Of Trustees Of Southern Illinois University Soybean resistant to cyst nematodes
US10059999B2 (en) 2013-06-10 2018-08-28 Monsanto Technology Llc Molecular markers associated with soybean tolerance to low iron growth conditions
NZ735461A (en) 2013-11-27 2020-05-29 Seminis Vegetable Seeds Inc Disease resistance loci in onion
UA122122C2 (uk) 2014-02-21 2020-09-25 Сінгента Партісіпейшнс Аг Спосіб виявлення рослини маїсу, що має підвищену чоловічу фертильність
NZ630710A (en) 2014-02-27 2016-03-31 Seminis Vegetable Seeds Inc Compositions and methods for peronospora resistance in spinach
US10316369B2 (en) 2014-06-27 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and assays for male sterile watermelon
EP3005862A1 (en) 2014-10-10 2016-04-13 Seminis Vegetable Seeds, Inc. Melon plants with improved disease tolerance
US10448595B2 (en) 2015-09-03 2019-10-22 Seminis Vegetable Seeds, Inc. Downy mildew resistant lettuce plants
EP3199642A1 (en) 2016-02-01 2017-08-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Plant breeding using high throughput sequencing
KR102491013B1 (ko) 2016-03-24 2023-01-31 코테라 바이오사이언스 인코포레이티드 Tg02를 사용한 암의 치료
AU2017250076B2 (en) 2016-04-12 2021-07-22 The Regents Of The University Of Michigan Bet protein degraders
ES2857743T3 (es) 2016-09-13 2021-09-29 Univ Michigan Regents 1,4-diazepinas fusionadas como degradadores de proteína BET
JP6961684B2 (ja) 2016-09-13 2021-11-05 ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン Betタンパク質分解物質としての縮合1,4−オキサゼピン
AU2017232187B2 (en) 2016-09-30 2023-11-09 Seminis Vegetable Seeds, Inc. Xanthomonas resistant brassica oleracea plants
EP3669279A4 (en) 2017-08-14 2021-05-05 Epizyme, Inc. METHOD OF TREATMENT OF CANCER BY INHIBITION OF SETD2
WO2019035985A1 (en) 2017-08-18 2019-02-21 Tragara Pharmaceuticals, Inc. POLYMORPHIC FORM OF TG02
WO2019055444A1 (en) 2017-09-13 2019-03-21 The Regents Of The University Of Michigan DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS
JP2022504541A (ja) 2018-10-08 2022-01-13 ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン 低分子mdm2タンパク質デグレーダー
AU2020208190B2 (en) 2019-01-15 2022-07-28 Seminis Vegetable Seeds, Inc. Green bean plants with improved disease resistance
EP3983084A1 (en) 2019-06-12 2022-04-20 Vanderbilt University Amino acid transport inhibitors and the uses thereof
US20220265590A1 (en) 2019-06-12 2022-08-25 Vanderbilt University Dibenzylamines as amino acid transport inhibitors
SG10202008262UA (en) 2019-09-26 2021-04-29 Seminis Vegetable Seeds Inc Lettuce plants having resistance to nasonovia ribisnigri biotype nr:1
AU2021204717A1 (en) 2020-07-15 2022-02-03 Seminis Vegetable Seeds, Inc. Green Bean Plants with Improved Disease Resistance
US20230193310A1 (en) 2021-12-10 2023-06-22 Seminis Vegetabe Seeds, Inc. Lettuce plants having resistance to downy mildew
WO2023250288A2 (en) 2022-06-21 2023-12-28 Seminis Vegetable Seeds, Inc. Novel qtls conferring resistance to cucumber mosaic virus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941876A (en) * 1973-04-25 1976-03-02 Gte New Ventures Corporation In vitro method for determining allergic hypersensitivity
FR2233024A1 (en) * 1973-06-15 1975-01-10 Greyward Lab Interconti Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen
US3979509A (en) * 1974-09-03 1976-09-07 General Electric Company Opaque layer method for detecting biological particles
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4094759A (en) * 1975-01-03 1978-06-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for simultaneous quantitative analysis of several constituents in a sample
US4097149A (en) * 1975-02-03 1978-06-27 Aladjem Frederick J Quantitative protein analysis by immunodiffusion
FR2353856A1 (fr) * 1976-06-02 1977-12-30 Chateau Guy Ruban destine a servir de support a une reaction par exemple chimique ou biochimique, et procede d'analyse le mettant en oeuvre
US4294817A (en) * 1977-11-25 1981-10-13 International Diagnostic Technology, Inc. Method of fluoro immunoassay
DK138080A (da) * 1979-04-02 1980-10-03 Research Corp Fremgangsmaade til serologisk undersoegelse af kilder som mistaenkes for at indeholde antistoffer mod chlamydia trachomatis

Also Published As

Publication number Publication date
CA1167376A (en) 1984-05-15
NO821569L (no) 1982-05-12
DK232882A (da) 1982-05-24
EP0050424B1 (en) 1985-09-18
ES8303072A1 (es) 1983-02-01
EP0050424A1 (en) 1982-04-28
DE3172347D1 (en) 1985-10-24
IL63907A0 (en) 1981-12-31
WO1982001011A1 (en) 1982-04-01
JPS57501692A (ja) 1982-09-16
ES505713A0 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
BR8108820A (pt) Processo e sonda de diagnostico
BR8108113A (pt) Dispositivo de analise e processo de aplicacao do mesmo
BR8101370A (pt) Sonda esofageana
BR8009056A (pt) Processo e aperelho de misturador
BR8101154A (pt) Instrumento de grampeamento cirurgico e bigorna
AR229779A1 (es) Conjunto de sonda
BR7705256A (pt) Processo e preparacao de eteno
IT1096588B (it) Processo per la preparazione di aralchilfenoleteri e di alchilfenoleteri
BR8100214A (pt) Sonda rotativa e processo de furacao
IT1092192B (it) Aparecchio e procedimento di filatura diretta
BR8007386A (pt) Processo e aparelho de amarracao de artigos
DK408080A (da) Testilbehandlingsmiddel
BR7905539A (pt) Processo de ensaio de pocos
BR8101187A (pt) Envoltorio de sonda para aparelho de diagrafia e processo de sua fabricacao
BR8102968A (pt) Processo de sintese de cloroformiatos - clorados e cloroformiatos - clorados
BR8104565A (pt) Catalisador e processo de preparacao de catalisador
AR224758A1 (es) Metodo y aparato de perfilado de pozos
BR7802606A (pt) Processo e aparelho de criodessecamento por hiperfrequencia
FI811603L (fi) Ionspecifikt diagnostiskt foerfarande och anordning
DD230151A3 (de) Kryochirurgisches instrument
IT1193576B (it) 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi
BR7801587A (pt) Processo para enriquecimento e separacao de tritio e/ou hidreto de tritio de agua de tritio
BR8101369A (pt) Sonda esofageana
IT1142142B (it) 5alfa-androstan-17beta-carbossilati e 5beta-androstan-17beta-carbossilati
IT1099505B (it) A-aminometilen-b-formilaminopropionitrile e processo per la sua preparazione